Physician profile
Ralph Rahme
NPI 1194046201
$6,750.23
in general payments reported to CMS, 2019-2025
14 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,840 · 2021: $515 · 2022: $2,085 · 2023: $161 · 2024: $146 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.43 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,796.81 | 2019-2025 | Broadway 8, Universal Neuro 3, Trevo |
| Penumbra, INC. | $2,148.21 | 2019 | |
| Vb Spine LLC | $559.73 | 2025 | Yukon Oct Spinal System |
| Phenox INC. | $175.00 | 2021 | |
| Zap Surgical Systems, INC. | $164.29 | 2021 | |
| Depuy Synthes Sales INC. | $163.43 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $160.69 | 2023 | Andexxa |
| Microvention, INC. | $142.99 | 2019 | |
| Djo, LLC | $134.58 | 2025 | Cmf |
| Integra Lifesciences Corporation | $115.32 | 2024-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Meticuly INC. | $62.15 | 2024 | Meticuly Patient-Specific Titanium Mesh Implant |
| Ossdsign USA Incorporated | $54.91 | 2025 | Ossdsign Catalyst |
| Zimmer Biomet Holdings, INC. | $50.92 | 2024-2025 | Neuro Plating System |
| Portola Pharmaceuticals, LLC | $21.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Rahme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.